Mineralys Therapeutics (MLYS) Net Margin (2022 - 2026)
Mineralys Therapeutics (MLYS) recorded Net Margin of -4864.23% in Q2 2026, down 3618.57 percentage points from -1245.65% a year earlier and down 4208.14 percentage points from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Net Margin (2022 - 2026) Analysis & Trends
On a TTM basis, Mineralys Therapeutics' Net Margin came in at -1649.80% as of Jun 30, 2026, down 98.29 percentage points year-over-year; for FY2025, it was -969.72%, up 249.15 percentage points from FY2024.
- Annual Net Margin has a three-year change of +808.26 percentage points (FY2022 to FY2025).
- Across earlier years, Net Margin came in at -1218.88% in FY2024 (-655.24 pp), -563.64% in FY2023 (+1214.34 pp) and -1777.98% in FY2022.
- The Q2 2026 figure is the lowest quarterly Net Margin in data going back to Q3 2022.
- On a year-over-year basis, Net Margin rose in three of the last eight quarters, with an average year-over-year change of -468.36 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 1229.17 percentage points in Q1 2026, against a drop of 3618.57 percentage points in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -656.09% (Q1 2026), -534.04% (Q4 2025) and -880.38% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 19.55% |
| 10 | Mineralys Therapeutics | 1.42 Bn | -1.17 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,864.23% |
| Mar 31, 2026 | -656.09% |
| Dec 31, 2025 | -534.04% |
| Sep 30, 2025 | -880.38% |
| Jun 30, 2025 | -1,245.65% |
| Mar 31, 2025 | -1,885.26% |
| Dec 31, 2024 | -1,742.47% |
| Sep 30, 2024 | -1,492.90% |
| Jun 30, 2024 | -987.81% |
| Mar 31, 2024 | -817.75% |
| Dec 31, 2023 | -734.39% |
| Sep 30, 2023 | -647.88% |
| Jun 30, 2023 | -337.91% |
| Mar 31, 2023 | -541.35% |
| Dec 31, 2022 | -970.37% |
| Sep 30, 2022 | -901.21% |
API Access
Mineralys Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();